Menopause Hormone Therapy and the Heart: 52,330 Women, 12 Years (AHA 2026) A preliminary study presented at the American Heart Association Scientific Sessions 2026 followed 52,330 women in Israel aged 45 to 59 for an average of 12 years. None had a history of heart disease, blood clots or cancer. Heart events occurred in 4.4% of women who started modern therapy and 4.6% of similar women who did not. Blood clots were 0.33% in both groups; death before age 80 was 1.3% vs 1.2%. Results were similar for pills, patches and gels. Limits: observational and not yet peer reviewed; therapy treats symptoms, not heart disease. Education only; a licensed provider decides every treatment. Does menopause hormone therapy raise heart attack risk for women aged 45 to 59? In a large early study of 52,330 women aged 45 to 59, heart events were similar over 12 years. They were 4.4% with modern therapy vs 4.6% without. HOO Longevity in the United States connects you with a licensed provider who reviews your heart history before any plan. Sources: American Heart Association Scientific Sessions 2026 (abstract), 2026: https://newsroom.heart.org/news/long-term-study-finds-modern-hormone-replacement-therapy-not-linked-to-heart-disease-risk Learn this with HOO Longevity Academy by Join HOO Health: research-backed lessons and a new reel, carousel and story every day, in your own brand. Free Academy Live class every Tuesday evening. joinhoohealth.com/academy Education only, not medical advice. Rx programs require an online visit with a licensed provider. Results vary. #menopause #perimenopause #womenshealth #Shorts #HOOLongevityAcademy #JoinHOOHealth